Diagnosis requires a combination of clinical performance, imaging, laboratory testing, and pathological activation. The platform can help align teams of authoritative experts at home and abroad to provide accurate diagnosis and treatment plans. Individualised treatment plans for treatment and management of diabetes mellitus intermittent needs to be developed, typically including drug therapy, rehabilitation interventions, regular follow-up, and more.
In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, many previously difficult to treat genetic metabolic diseases have been significantly improved. Treatment needs to be closely monitored for efficacy and adverse reactions, adjusted in a timely manner depending on the changes in the disease. Multidisciplinary collaboration (MDT) is particularly important for the integrated management of intermittent type of diabetes.
The platform serves a team of nationally and internationally authoritative experts in the field of genetic metabolism in the Chinese international medical service system, providing the following services to patients: 2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment programs; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4.
Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.